Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|SCC244||Glumetinib|SCC-244|SCC 244||SCC244 (Glumetinib) is an ATP-competitive inhibitor of MET, which may lead to cell-cycle arrest, decreased cell proliferation, and inhibition of tumor growth (PMID: 29237805).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT04270591||Phase Ib/II||SCC244||Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer||Recruiting||USA||2|